AYTU
AYTU BIOPHARMA, INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.12
+6.00%Next report
Analyst consensus
- Next report date
- Sep 22, 2026
- EPS estimate
- -$0.29
- Revenue estimate
- $12.3M
Latest reported
- Last report date
- May 13, 2026
- EPS actual
- -$0.53
- EPS estimate
- -$0.31
- Revenue actual
- $12.4M
- Revenue estimate
- $12.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -402.0%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 13, 2026 | -$0.31 | -$0.53 | Miss -70.97% | $12.4M |
| Feb 3, 2026 | -$0.26 | -$1.05 | Miss -303.85% | $15.2M |
| Nov 13, 2025 | -$0.06 | -$0.08 | Miss -33.33% | $13.9M |
| Sep 23, 2025 | -$0.02 | -$0.26 | Miss -1200.00% | $15.1M |
| Feb 12, 2025 | -$0.28 | -$0.28 | In line | $16.2M |
| Sep 26, 2024 | -$0.45 | -$0.82 | Miss -82.22% | $18.0M |
| May 15, 2024 | -$0.64 | -$0.52 | Beat 18.75% | $18.0M |
| Feb 14, 2024 | -$0.25 | -$0.04 | Beat 84.00% | $22.9M |
| Nov 14, 2023 | -$0.04 | -$1.48 | Miss -3600.00% | $22.1M |
| May 11, 2023 | -$0.63 | -$1.93 | Miss -206.35% | $22.7M |
| Feb 21, 2023 | $0.20 | -$1.31 | Miss -755.00% | $26.3M |
| Nov 14, 2022 | -$3.60 | -$1.20 | Beat 66.67% | $27.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 22, 2026